Medical News

RSS

Certain molecules found to play an important role in regulating circadian rhythm: Study

Molecules that may hold the key to new ways to fight cancer and other diseases have been found to play an important role in regulating circadian rhythm, says Liheng Shi, a researcher in Texas A&M's Department of Veterinary Integrative Biosciences.

21 Oct 2009

Research suggests latent cytomegalovirus infection exacerbates inflammatory bowel disease

Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology.

21 Oct 2009

Curis to outline Hedgehog Pathway Inhibitor at Annual BIO Investor Forum

Curis, Inc. , a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 8th Annual BIO Investor Forum at 4:30 p.m. PDT (7:30 p.m. EDT) on October 28, 2009, at the Palace Hotel in San Francisco, California.

21 Oct 2009

Growth of EOTSs has slowed in recent years, reveals study

Researchers have found recent evidence that shows the growth of external, off-hours teleradiology services (EOTSs) has slowed in recent years, despite a significant increase in the number of radiology practices using those services between 2003 and 2007, according to a study in the November issue of the American Journal of Roentgenology.

21 Oct 2009

OR Benchmarks Collaborative names the 2009 Top Performers

Faced with today’s unrelenting financial demands and quality of care challenges, leading hospitals and ambulatory surgery centers are turning to comparative healthcare benchmarks to help them improve operating room (OR) performance. Six of these trailblazers have been recognized by one such service, the OR Benchmarks® Collaborative (ORBC), as 2009 Top Performers that have used ORBC data to achieve significant results.

21 Oct 2009

Beth Israel Deaconess Medical Center collaborates with Navigenics to make personalized genomics available to doctors in training

Beth Israel Deaconess Medical Center and Navigenics, Inc., a leading personal genomics company, today announced a collaboration to make personalized genomics available to doctors in training.

21 Oct 2009

EMEA informs Antigenics on a negative opinion for Oncophage MAA

Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMEA), has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) in early-stage, localized renal cell carcinoma (kidney cancer).

21 Oct 2009

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company’s experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.

21 Oct 2009

Auxano point-of-care indicator system for dry eye syndrome

Auxano Diagnostics, LLC, a subsidiary of Auxano Biomedical, LLC, has announced the application of the company’s breakthrough wound care technology to the treatment of dry eye syndrome (DES) with the Auxano point-of-care indicator system.

21 Oct 2009

Bionate II PCU launched by DSM Biomedical

DSM PTG, part of DSM Biomedical, a global leader in biomedical materials science, today announced the availability of Bionate® II PCU, a versatile medical polymer with built-in surface technology designed for chronic implants.

21 Oct 2009

Genesis Health System implements AeroScout's hospital-wide asset tracking and management system

AeroScout, the leading provider of Unified Asset Visibility for the healthcare industry, today announced that Genesis Health System has implemented AeroScout’s Wi-Fi RTLS (real time location system) for hospital-wide asset tracking and management at Genesis Medical Center in Davenport, Iowa. Genesis uses the AeroScout solution to improve staff efficiency, optimize maintenance of medical equipment and reduce operational and capital expenses associated with renting additional devices and purchasing equipment.

21 Oct 2009

Women Veterans had a lower prevalence of pain than male counterparts returning from the conflicts: Study

In the first study to look at sex-specific pain prevalence in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans, researchers from the VA Connecticut Healthcare System and the Yale University School of Medicine found women Veterans had a lower prevalence of pain than male counterparts returning from the conflicts. Approximately 60% of OEF/OIF Veterans were assessed with pain during the study period.

21 Oct 2009

Addition of chiropractic care increases value in US employer-sponsored health benefit plans

A report, prepared by a global leader for trusted human resources and related financial advice, products and services, finds that the addition of chiropractic care for the treatment of low back and neck pain will likely increase value-for-dollar in US employer-sponsored health benefit plans.

21 Oct 2009

Positive results from Argos Therapeutics' personalized immunotherapy candidate AGS-004 Phase 2a trial

Argos Therapeutics today announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. AGS-004 is a product of the Company’s Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient’s unique HIV viral burden.

21 Oct 2009

AGA Medical Holdings to offer 13,750,000 shares of common stock at $14.50 per share

AGA Medical Holdings, Inc. (the “Company”) announced the pricing of its initial public offering of 13,750,000 shares of common stock at $14.50 per share. The Company expects to sell 6,509,000 shares, and 7,241,000 shares are expected to be sold by the selling stockholders. The offering is expected to close on October 26, 2009.

21 Oct 2009

UW researchers suggest approaches for treating depression in older cancer patients

Depression in older cancer patients is very common, and has debilitating effects on their quality of life both during and after treatment. University of Washington (UW) researchers are showing that there are ways to better this situation.

21 Oct 2009

University of Granada scientists develop a new forensic technique for identifying persons missing in armed conflicts

A research work carried out at the Laboratory of Forensic Anthropology of the University of Granada will speed up the identification of more than 2,000 missing persons in Kosovo during former Yugoslavia war, besides developing a new forensic technique based on the study of ribs and pubis, which will be very useful for the identification of persons in armed conflicts. This work, pioneer all over the world, has involved the study of one of the greatest forensic samples never before analysed.

21 Oct 2009

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).

21 Oct 2009

China Medical Technologies to exhibit medical equipment from its three advanced IVD business lines

China Medical Technologies, Inc. (the "Company"), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will attend the 62nd China International Medical Equipment Fair ("CMEF") from October 28 to October 31, 2009 in Chengdu, China.

21 Oct 2009

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

The Swine Flu (H1N1)Vaccine is starting to arrive at health departments, hospitals, and community vaccinator facilities.

21 Oct 2009

Medical News

Certain molecules found to play an important role in regulating circadian rhythm: Study

Research suggests latent cytomegalovirus infection exacerbates inflammatory bowel disease

Curis to outline Hedgehog Pathway Inhibitor at Annual BIO Investor Forum

Growth of EOTSs has slowed in recent years, reveals study

OR Benchmarks Collaborative names the 2009 Top Performers

Beth Israel Deaconess Medical Center collaborates with Navigenics to make personalized genomics available to doctors in training

EMEA informs Antigenics on a negative opinion for Oncophage MAA

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Auxano point-of-care indicator system for dry eye syndrome

Bionate II PCU launched by DSM Biomedical

Genesis Health System implements AeroScout's hospital-wide asset tracking and management system

Women Veterans had a lower prevalence of pain than male counterparts returning from the conflicts: Study

Addition of chiropractic care increases value in US employer-sponsored health benefit plans

Positive results from Argos Therapeutics' personalized immunotherapy candidate AGS-004 Phase 2a trial

AGA Medical Holdings to offer 13,750,000 shares of common stock at $14.50 per share

UW researchers suggest approaches for treating depression in older cancer patients

University of Granada scientists develop a new forensic technique for identifying persons missing in armed conflicts

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

China Medical Technologies to exhibit medical equipment from its three advanced IVD business lines

Swine flu vaccines arrive at health departments, hospitals and community vaccinator facilities

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News